February 2018 Vol 11, No 1

Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines

Bruce S. Pyenson, FSA, MAAA; Gabriela Dieguez, FSA, MAAA; Christine Ferro; Maushumi Mavinkurve, MPH; Yuri Sanchez Gonzalez, PhD

Stakeholder Perspective

Importance of Health Outcomes Research for the Treatment of Hepatitis C Infection

Jack E. Fincham, PhD, RPh

Business, Original Research

Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States

Eric M. Maiese, MHS, PhD; Kristin A. Evans, PhD; Bong-Chul Chu, PhD; Debra E. Irwin, MSPH, PhD

Stakeholder Perspective

Improved Clinical Outcomes with Newer Multiple Myeloma Therapies Associated with Increased Resource Utilization and Financial Burden

Matthew Mitchell, PharmD, MBA, FAMCP

Editorial

Still at It

David B. Nash, MD, MBA

Clinical

Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States

J. Douglas Thornton, PharmD, PhD; Nilanjana Dwibedi, PhD; Virginia Scott, PhD; Charles D. Ponte, PharmD; Douglas Ziedonis, MD; Nethra Sambamoorthi, PhD; Usha Sambamoorthi, PhD

Stakeholder Perspective

Addiction Prediction: Preventing Iatrogenic Opioid Dependence

Albert Tzeel, MD, MHSA, CPE, FAAPL

Industry Trends

Healthcare Trends for 2018

F. Randy Vogenberg, PhD, RPh; John Santilli, MBA

Results 1 - 5 of 5

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.